Social Entropy

  • Patrick L. Iversen


We find ourselves in the “information age” with immediate access to limitless information but almost no reliable filter to distill quality from the contaminated volume. We are compelled to probe the limits of our existence often engaging in activities that threaten our health and survival. Central to the theme of this chapter an overview of health boundaries and the phenomenal biological adaptability rooted in the core of molecular biology. Genes are not digital switches in either zero or one position but are dynamic structures capable of responding to the smallest molecules in the environment. This instant genetic adaptability leads to cell physiology that is an ordered chaos leading to multiple possible outcomes following exposure to both subtle and extreme environments. Individuals are unintelligent, thoughtless creatures entrenched in a daily random walk but are capable of genius when taken together as populations. We are the collective result of interacting gene expression events, each of which adapts to a complex matrix of chemical signals, both endogenous and from the environs. Life is often threatened but is not that fragile.


Smoking Radiation Overpopulation Olympics Telomeres Telomerase Progeria 


  1. Abdel-Ghaffar TY, et al. Hepatitis C genotype 4: the past, present and future. World J Hepatol. 2015;7:2792–810.CrossRefGoogle Scholar
  2. Anderson M, Shanmuganayagam D, Weindruch R. Caloric restriction and aging studies in mice and monkeys. Toxicol Pathol. 2009;37(1):47–51.CrossRefGoogle Scholar
  3. Bessaud et al. Molecular characterization of human Enterovirus in the Central African Republic: Uncovering wide diversity and identification of a new human enterovirus A71 genogroup. J Clin Micro. 2012;50(5):1650–1658.CrossRefGoogle Scholar
  4. Bierut LJ, Stitzel JA, Wang JC, et al. Nicotine dependence and the a5-a3-b4 nicotinic receptor gene cluster: variants in the nicotinic receptors alter the risk for nicotine dependence. Am J Psychiatry. 2008;9(185):1163–71.CrossRefGoogle Scholar
  5. Black RE, Allen LH, Bhutta ZA, Caulfield LE, do Onis M, Ezzati M, Mathers C, Rivera J. Maternal and child undernutrition: global and regional exposures and helath consequences. Lancet. 2008;371(9608):243–60.CrossRefGoogle Scholar
  6. Blasco MA. Telomeres and human disease: aging, cancer and beyond. Nat Rev Genet. 2005;6(8):611–22.CrossRefGoogle Scholar
  7. Blotkin DB. Myth 4: the balance of nature exists and dominates all life and all environments. In: 25 Myths that are destroying the environment. Guilford: Taylor Trade Publishing; 2017. p. 35–48.Google Scholar
  8. Borella E, Nesher G, Israeli E, Shoenfeld Y. Vitamin D: a new anti-infective agent? Ann N Y Acad Sci. 2014;1317:76–83.CrossRefGoogle Scholar
  9. Borger J. Feed the world? We are fighting a losing battle, UN admits. London: The Guardian; 2008, Feb 26.Google Scholar
  10. Buchanan E. Assessing the global food crisis. BBC News. 2008, April 22.Google Scholar
  11. Burchett KM, Yan Y, Ouellette MM. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. PLoS One. 2014;9(1):e85155.CrossRefGoogle Scholar
  12. Buseman CM, Wright WE, Shay JW. Is telomerase a viable target in cancer? Mutat Res. 2012;730:90–7.CrossRefGoogle Scholar
  13. Chaabna K, et al. Hepatitis C virus epidemiology in Djibouti, Somalia, Sudan, and Yemen: systematic review and meta-analysis. PLoS One. 2016;11:e0149966.CrossRefGoogle Scholar
  14. Chancey C, et al. The global ecology and epidemiology of west Nile virus. BioMed Res Int. 2015;2015:1–20.CrossRefGoogle Scholar
  15. Chen LS, Hung RJ, Baker T, et al. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis- a meta-analysis. J Natl Cancer Inst. 2015;107(5)
  16. Chiappori AA, Kolevska T, Spigel DR, Hager S, Rager S, Rarick M, Gadgeel S, Blais N, Von Pawel J, Hart L, Reck M, Bassett E, Burington E, Burington B, Schiller JH. A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer. Ann Oncol. 2015;26(2):354–62.CrossRefGoogle Scholar
  17. Christi MJ, Tebruegge M, La Vincente S, Graham SM, Duke T. Pneumonia in severly malnourished children in developing countries- mortality risk, aetiology, and validity of WHO clinical signs: a systemic review. Trop Med Int Health TM IH. 2009;14:1173–89.CrossRefGoogle Scholar
  18. Christian Science Monitor. The global grain bubble. 2008, January 18. NCT00594126.
  19. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Aville E, Meish F, Milenkovic D, Tobin J, Charlier C, Georges M. A mutation creating a potential illegitimate micro RNA target site in the myostatin gene affects muscularity in sheep. Nat Genet. 2006;38(7):813–8.CrossRefGoogle Scholar
  20. CNN Money. Oil stock could push world food prices higher. 2011, March 3.Google Scholar
  21. Cusanelli E, Chartrand P. Telomeric repeat-containing RNA TERRA: a noncoding RNA connecting telomere biology to genome integrity. Front Genet. 2015;6:143.CrossRefGoogle Scholar
  22. Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Lauritsch I, Muller E, Pascolo E, Sauter G, Pantic M, Martens UM, Wenz C, Lingner J, Kraut N, Rettig WJ, Schnapp A. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 2001;20:6958–68.CrossRefGoogle Scholar
  23. Dikmen AG, Gellert GC, Jackson S, Gryaznov S, Tressler R, Dogan P, Wright WE, Shay JW. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Cancer Res. 2005;65(17):7866–73.CrossRefGoogle Scholar
  24. Dunn R. In retrospect: silent spring. Nature. 2012;485:578–9. Scholar
  25. El-Daly H, Kull M, Zimmermann S, Pantic M, Waller CF, Martens UM. Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. Blood. 2006;105:1742–9.CrossRefGoogle Scholar
  26. Fallah MP, Skrip LA, Gertler S, Yamin D, Galvani AP. Quantifying poverty as a driver of ebola transmission. PLoS Negl Trop Dis. 2015;9(12):e0004260. Pub Med PMID: 26720278CrossRefGoogle Scholar
  27. Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA. Temporary remissions in acute leukemia in children produced by falic acid antagonist, 4-aminopteroyl-glutamic acid (Aminopterin). N Engl J Med. 1948;238(787):787–93.CrossRefGoogle Scholar
  28. Gilford H, Shepherd RC. Ateleiosis and progeria continuous youth and premature old age. Br Med J. 1904;2(5157):914–8.Google Scholar
  29. Global prevalence of vitamin A deficiency in populations at risk 1995–2005. WHO global database on vitamin A deficiency. Geneva: World Health Organization; 2009.Google Scholar
  30. Goldblatt EM, Gentry ER, Fox MJ, Gryaznov SM, Shen C, Herbert BS. The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments effects of paclitaxel. Mol Cancer Ther. 2009;8(7):2027–35.CrossRefGoogle Scholar
  31. Gomez D, Lemarteleur T, Lacroix L, Mailliet P, Mergny JL, Riou JF. Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res. 2004;32(1):371–9.CrossRefGoogle Scholar
  32. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985;43(2 pt 1):405–13.CrossRefGoogle Scholar
  33. Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilins; 2012. p. 120–1.Google Scholar
  34. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life etends lifespan in genetically heterogenous mice. Nature. 2009;460:392–5.CrossRefGoogle Scholar
  35. Hashimoto T, Kunieda T. DNA protection protein, a novel mechanism of radiation tolerance: lessons from tardigrades. Life. 2017;26 Scholar
  36. Hayflick L, Moorehead PS. The limited in vitro lifetime of human diploid cell strains. Exp Aging Res. 1961;25:585–621.Google Scholar
  37. Hengherr S, Worland MR, Reuner A, Brummer F, Schill RO. High-temperature tolerance in anhydrobiotic tardigrades is limited by glass transition. Physiol Biochem Zool. 2009;82:749–55.CrossRefGoogle Scholar
  38. Hennekam RC. Hutchinson-Gilford progeria syndrome review of the phenotype. Am J Med Genet A. 2006;140(23):2603–24.CrossRefGoogle Scholar
  39. Herbert BS, Gellert GC, Hochreiter A, Pongracz K, Wright WE, Zielinska D, Chin AC, Harley CB, Shay JW, Gryaznov SM. Lipid modification of GRN163, an N3’-P5’ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition. Oncogene. 2005;24(33):5262–8.CrossRefGoogle Scholar
  40. Hewison M. Vitamin D and innate and adaptive immunity. Vitam Horm. 2011;86:23–62.CrossRefGoogle Scholar
  41. Heylen, et al. Rotavirus surveillance in Kisangani, the Democratic Republic of the Congo, reveals a high number of unusual genotypes and gene segments of animal origin in non-vaccinated symptomatic children. PLoS One. 2014;9:e100953.CrossRefGoogle Scholar
  42. Horikawa DD, Sakashita T, Katagiti C, Watanabe M, Kikawada T, Nakahara Y, Hamada N, Wada S, et al. Radiation tolerance in the tardigrade Milnesium tardigradum. Int J Radiat Biol. 2006;82:843–8.CrossRefGoogle Scholar
  43. Huether S, McCance K. “20” Understanding pathophysiology. 3rd ed. Mosby; 2004. p 543.Google Scholar
  44. Hutchinson J. Case of congenital absence of hair, with atrophic condition of the skin and its appendages, in a boy whose mother had been almost wholly bald from alopecia from the age of six. Lancet. 1986;1(3272):923.Google Scholar
  45. Iversen PR. The Centennial of a great idea. Kalispell: Scott Company Publishing; 2016.Google Scholar
  46. Jackson AC, Johannsen EC. Harrison’s infectious disease (Kasper DL, Fauci AS(eds)) Ch 98. 2010. pp. 959–965.Google Scholar
  47. Kaeberlin M. Resveratrol, pterostilbene and rapamycin: are they anti-aging drugs? BioEssays. 2010;32(2):96–9.CrossRefGoogle Scholar
  48. Kambadur R, Sharma M, Smith TP, Bass JJ. Mutations in myostatin (GDF8) in double-muscled Belgian blue and Piedmontese cattle. Genome Res. 1997;7(9):910–6.CrossRefGoogle Scholar
  49. Kearns MD, Alvarez JA, Seidel N, Tangpricha V. Impact of vitamin D on infectious disease. Am J Med Sci. 2015;349(3):245–62. Review. Pub Med PMID: 25334038CrossRefGoogle Scholar
  50. Kim MY, Gleason-Guzman M, Izbicka E, Nishioka D, Hurley LH. The different biological effects of Telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. Cancer Res. 2003;63:3247–56.PubMedGoogle Scholar
  51. Kota J, Handy CR, Haidet AM, Montgomery CL, Eagle A, Radino-Klapac LR, Tucker D, Schilling CJ, Therlfall WR, Walker CM, Weisbrode SE, Janssen PM, Clark KR, Sahenk Z, Mendell JP, Kaspar BK. Follistatin gen delivery enhances muscle growth and strength in nonhuman primates. Sci Transl Med. 2009;1(6):6ra15.CrossRefGoogle Scholar
  52. L’Huillier AG, et al. Moleculr epidemiology of human rhinoviruses and enteroviruses highlights their diversity in sub-Saharan Africa. Viruses. 2015;7:6412–23.CrossRefGoogle Scholar
  53. Listerman I, Sun J, Gazzaniga FS, Lukas JL, Blackburn EH. The major reverse transcriptase-incompetent splice variant of human telomerase protein inhibits telomerase activity but protects from apoptosis. Cancer Res. 2013;73:2817–1828.CrossRefGoogle Scholar
  54. Lwande et al. Infec Ecol Epidemiol. 2015; 5:29853.Google Scholar
  55. Mahaffey J. The military almost never lost a nuclear weapon. New York: Atomic Accidents Pegasus Books; 2014. p. 286–324.Google Scholar
  56. Marshall AL, Christiani DC. Genetic susceptibility to lung cancer- light at the end of the tunnel? Carcinogenesis. 2013;34(3):487–502.CrossRefGoogle Scholar
  57. Mata JE, Joshi SS, Palen B, Pirruccello SJ, Jackson JD, Elias N, Page TJ, Medlin KL, Iversen PL. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt’s lymphoma cells in vitro and in vivo. Toxicol Appl Pharmacol. 1997;144:189–97.CrossRefGoogle Scholar
  58. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387(6628):83–90.CrossRefGoogle Scholar
  59. Miragliotta G, Miragliotta L. Vitamin D and infectious diseases. Endocr Metab Immune Disord Drug Targets. 2014;14(4):267–71. ReviewCrossRefGoogle Scholar
  60. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take center stage. Nat Rev Immunol. 2008;8(9):685–98. Pub Med PMID: 19172691; Pub Med Central PMCID: PMC2906676CrossRefPubMedPubMedCentralGoogle Scholar
  61. Mosher DS, Auignon P, Bustamante CD, Sutter NB, Mellersh CS, Parker HG, Ostrander EA. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet. 2007;3(5):e79.CrossRefGoogle Scholar
  62. Muller H. The remaking of chromosomes. The collecting net. Woods Hole. 1938;13:181–98.Google Scholar
  63. Nair MK, Augustine LF, Konapur A. Food-based interventions to modify diet quality and diversity to address multiple micronutrient deficiency. Front Public Health. 2016;3:277. Review. PMID: 26779472CrossRefGoogle Scholar
  64. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973;41:181–90.CrossRefGoogle Scholar
  65. Ono F, Saigusa M, Uozumi T, Matsushima Y, Ikeda H, Saini NL, Yamashita M. Effect of high hydrostatic pressure on to life of the tiny animal tardigrade. J Phys Chem Solids. 2008;69:2297–300.CrossRefGoogle Scholar
  66. Page TJ, Mata JE, Bridge JA, Siebler JC, Neff JR, Iversen PL. The cytotoxic effects of single-stranded telomere mimics on MOA-BL1 cells. Exp Cell Res. 1999;252:41–9.CrossRefGoogle Scholar
  67. Parpia AS, et al. Effects of response to 2014-2015 Ebola outbreak on deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerg Infect Dis. 2016;22:433–41.CrossRefGoogle Scholar
  68. Pascolo E, Wenz C, Lingner J, Hauel N, Priepke H, Kauffman I, Garin-Chesa P, Rettig WJ, Damm K, Schnapp A. Mechanism of human telomerase inhibition by BIBR 1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem. 2002;277:15566–72.CrossRefGoogle Scholar
  69. Pelletier DL, Frongillo EA, Schroeder DG, Habicht JP. The effects of malnutrition on child mortality in developing countries. Bull World Health Organ. 1995;73:443–8.PubMedPubMedCentralGoogle Scholar
  70. Pruzan R, Pongracz K, Gietzen K, Wallweber G, Gryaznov S. Allosteric inhibitors of telomerase: oligonucleotide N3’-P5’ phosphoramidates. Nucleic Acids Res. 2002;30(2):559–68.CrossRefGoogle Scholar
  71. Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systemic analysis from the global burden of disease study 2015. Lancet. 2017, April;389:1885–906. Scholar
  72. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953. Trans R Soc Trop Med Hyg. 1955;49:28–32.CrossRefGoogle Scholar
  73. Ross CA. Vitamin a and retinoic acid in T cell-related immunity. Am J Clin Nutr. 2012;96(suppl):1166S–72S.CrossRefGoogle Scholar
  74. Rudan I, et al. Reducing mortality from childhood pneumonia: The leading priority is also the greatest opportunity. J Glob Health. 2013;3(1): 010101Google Scholar
  75. Rytter MJH, Kolte L, Briend A, Friis H, Christensen VB. The immune system in children with malnutrition-A systematic review. PLoS One. 2014;9(8):e105017.CrossRefGoogle Scholar
  76. Scaffidi P, Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med. 2005;11(4):440–5.CrossRefGoogle Scholar
  77. Scaffidi P, Misteli T, Misteli. Lamin A-dependent nuclear defects in human aging. Science. 2006;312(5776):1059–63.CrossRefGoogle Scholar
  78. Schuelke M, Wagner KR, Stolz LE, Hubner C, Reibel T, Komen W, Braun T, Tobin JF, Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004;350(26):2682–8.CrossRefGoogle Scholar
  79. Shea-Herbert B, Pongracz K, Shay JW, Gryaznov SM. Oligonucleotide N3’→P5’ phophoramidates as efficient telomerase inhibitors. Oncogene. 2002;21:638–42.CrossRefGoogle Scholar
  80. Slaughter E, Gersberg RM, Watanabe K, Rudolph J, Stransky C, Novotny TE. Toxicity of cigarette butts, and their chemical components, to marine and freshwater fish. Tob Control. 2011;20:25–9.CrossRefGoogle Scholar
  81. Soenen S, Mariman EC, Vogels N, Bouman FG, den Hoed M, Brown L, Westerterp-Plantenga MS. Relationship between perilipin gen polymorphisms and body weight and body composition during weight loss and water maintenance. Physiol Behav. 2009;96(4–5):723–8.CrossRefGoogle Scholar
  82. The world litters 4.5 trillion cigarette butts a year. Can we stop this? The Houston Chronicle 2014.Google Scholar
  83. Thompson PA, Drissi R, Muscal JA, Panditharatna E, Fouladi M, Ingle AM, Ahern CH, Reid JM, Lin T, Weigel BJ, Blaney SM. A phase I trial of Imetelstat in children with refractory or recurrent solid tumors: a children’s oncology group phase I consortium study (ADVL1112). Clin Cancer Res. 2013;19(23):6578–84.CrossRefGoogle Scholar
  84. UNSCEAR. Sources and effects of ionizing radiation. Report of the United Nations Scientific Committee on the effects of atomic radiation. New York: United Nations; 2000.Google Scholar
  85. Vitamin A deficiency. UNICEF. 2015.Google Scholar
  86. Watson JD. Origin of concatameric T7 DNA. Nat New Biol. 1972;239:197–201.CrossRefGoogle Scholar
  87. Will G. We don’t need government to remind us that smoking kills. Editorial in the Grand Junction Daily Sentinal. 2017, December 28.Google Scholar
  88. Witkowske DH, et al. Lassa Virus in multimammate rats, Cote d’Ivoire. Emerg Infect Dis. 2015;21(8):1481–1483.Google Scholar
  89. Wolf G. Discovery of vitamin A. Enc Life Sci. 2001;
  90. Wong SM, Chen L, Foster C, Kainthla R, Shay JW, Wright WE. Regulation of telomerase alternate splicing: a new target for chemotherapy. Cell Rep. 2013;3:1028–35.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Patrick L. Iversen
    • 1
  1. 1.LS PharmaOregon State UniversityGrand JctUSA

Personalised recommendations